Inventor
FATHI REZA
US45 patents
⚠️ This page may combine multiple inventors who share the name “FATHI REZA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REDHILL BIOPHARMA LTD
34 patentsUS11052073B1Jul 6, 2021
Sphingosine kinase 2 inhibitor for treating coronavirus infection
REDHILL BIOPHARMA LTD6 citations83
US11045453B1Jun 29, 2021
Serine protease inhibitor for treating coronavirus infection
REDHILL BIOPHARMA LTD7 citations83
US10238606B2Mar 26, 2019
Pharmaceutical compositions for the treatment of Helicobacter pylori
REDHILL BIOPHARMA LTD6 citations83
US9603806B2Mar 28, 2017
Pharmaceutical compositions for the treatment of Helicobacter pylori
REDHILL BIOPHARMA LTD5 citations83
US9498445B2Nov 22, 2016
Pharmaceutical compositions for the treatment of Helicobacter pylori
REDHILL BIOPHARMA LTD7 citations83
US9844540B2Dec 19, 2017
Combination therapies for treating cancer
REDHILL BIOPHARMA LTD7 citations81
USD883801SMay 12, 2020
Blister package
REDHILL BIOPHARMA LTD7 citations76
US11918560B2Mar 5, 2024
Serine protease inhibitor for treating coronavirus infection
REDHILL BIOPHARMA LTD2 citations72
US11135172B2Oct 5, 2021
Rifabutin-based compositions and methods for treating Helicobacter pylori infection
REDHILL BIOPHARMA LTD2 citations72
US11090325B2Aug 17, 2021
Compositions for treating ebola virus infection
REDHILL BIOPHARMA LTD3 citations72
US10543222B2Jan 28, 2020
Therapy for inhibition of single-stranded RNA virus replication
REDHILL BIOPHARMA LTD3 citations72
US9974800B2May 22, 2018
Therapy for inhibition of single-stranded RNA virus replication
REDHILL BIOPHARMA LTD2 citations72
US10493065B2Dec 3, 2019
Formulations and methods of manufacturing formulations for use in colonic evacuation
REDHILL BIOPHARMA LTD2 citations70
US10166219B2Jan 1, 2019
Formulations and methods of manufacturing formulations for use in colonic evacuation
REDHILL BIOPHARMA LTD3 citations70
US9901638B2Feb 27, 2018
Composition and method for treating an autoimmune disease
REDHILL BIOPHARMA LTD2 citations69
US12551469B2Feb 17, 2026
Sphingosine kinase 2 inhibitor for treating coronavirus infection
REDHILL BIOPHARMA LTD0 citations62
US12502381B2Dec 23, 2025
Serine protease inhibitor for treating coronavirus infection
REDHILL BIOPHARMA LTD0 citations62
US12370206B2Jul 29, 2025
Therapy for inhibition of single-stranded RNA virus replication
REDHILL BIOPHARMA LTD0 citations62
US11786541B2Oct 17, 2023
Inhibitor of sphingosine kinase 2 for treating Ebola
REDHILL BIOPHARMA LTD0 citations62
US11364227B2Jun 21, 2022
Sphingosine kinase 2 inhibitor for treating coronavirus infection
REDHILL BIOPHARMA LTD0 citations62
US11931463B2Mar 19, 2024
All-in-one fixed-dose combination for treating Helicobacter pylori infection
REDHILL BIOPHARMA LTD0 citations61
US10898439B2Jan 26, 2021
Methods for treating helicobacter pylori infection
REDHILL BIOPHARMA LTD0 citations61
US11633385B2Apr 25, 2023
Combination compositions for treatment of cancer
REDHILL BIOPHARMA LTD0 citations60
US10946000B2Mar 16, 2021
Method for treating cancer with combination therapy
REDHILL BIOPHARMA LTD0 citations60
US11058671B2Jul 13, 2021
Formulations and methods of manufacturing formulations for use in colonic evacuation
REDHILL BIOPHARMA LTD0 citations59
US12115150B2Oct 15, 2024
Biomarkers of coronavirus pneumonia
REDHILL BIOPHARMA LTD0 citations58
US11471448B2Oct 18, 2022
Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia
REDHILL BIOPHARMA LTD0 citations58
US11590154B2Feb 28, 2023
Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections
REDHILL BIOPHARMA LTD0 citations56
US12569475B2Mar 10, 2026
Method for eradicating helicobacter pylori infection in patients regardless of body mass index
REDHILL BIOPHARMA LTD0 citations54
US11878011B2Jan 23, 2024
Method for eradicating Helicobacter pylori infection in patients regardless of body mass index
REDHILL BIOPHARMA LTD0 citations54
US10668050B2Jun 2, 2020
Compositions, methods and kits for treating diarrhea-predominant irritable bowel syndrome
REDHILL BIOPHARMA LTD0 citations51
US9675588B2Jun 13, 2017
Ondansetron extended release solid dosage forms for treating either nausea, vomiting or diarrhea symptoms
REDHILL BIOPHARMA LTD0 citations51
US10463654B2Nov 5, 2019
Combination therapies for treating cancer
REDHILL BIOPHARMA LTD0 citations49
US9636305B2May 2, 2017
Antiemetic extended release solid dosage forms
REDHILL BIOPHARMA LTD0 citations40
XTL BIOPHARMACEUTICALS LTD
4 patentsUS7994360B2Aug 9, 2011
Benzofuran compounds
XTL BIOPHARMACEUTICALS LTD0 citations48
US7148253B2Dec 12, 2006
4-thio coumarins
XTL BIOPHARMACEUTICALS LTD0 citations41
US8048889B2Nov 1, 2011
3,4-disubstituted coumarin and quinolone compounds
XTL BIOPHARMACEUTICALS LTD0 citations39
US7923004B2Apr 12, 2011
4-ethynyl pyrazole derivative compounds and methods for treatment of HCV
XTL BIOPHARMACEUTICALS LTD0 citations37